| Structural linkage between ligand discrimination and receptor activation by type I interferons C Thomas, I Moraga, D Levin, PO Krutzik, Y Podoplelova, A Trejo, C Lee, ... Cell 146 (4), 621-632, 2011 | 387 | 2011 |
| Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug‐Induced Oxidative Injury C Lee Oxidative medicine and cellular longevity 2017 (1), 1378175, 2017 | 143 | 2017 |
| Therapeutic modulation of virus‐induced oxidative stress via the Nrf2‐dependent antioxidative pathway C Lee Oxidative Medicine and Cellular Longevity 2018 (1), 6208067, 2018 | 133 | 2018 |
| Griffithsin, a highly potent broad-spectrum antiviral lectin from red algae: From discovery to clinical application C Lee Marine drugs 17 (10), 567, 2019 | 108 | 2019 |
| Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective C Lee, WJ Choi Archives of pharmacal research 44 (1), 99-116, 2021 | 96 | 2021 |
| The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein C Lee, H Ma, JQ Hang, V Leveque, EH Sklan, M Elazar, K Klumpp, ... Virology 414 (1), 10-18, 2011 | 96 | 2011 |
| Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B NJ Cho, H Dvory-Sobol, C Lee, SJ Cho, P Bryson, M Masek, M Elazar, ... Science translational medicine 2 (15), 15ra6-15ra6, 2010 | 75 | 2010 |
| CRISPR/Cas9-based antiviral strategy: current status and the potential challenge C Lee Molecules 24 (7), 1349, 2019 | 61 | 2019 |
| Immortalization of primary keratinocytes and its application to skin research M Choi, C Lee Biomolecules & therapeutics 23 (5), 391, 2015 | 60 | 2015 |
| Daclatasvir: potential role in hepatitis C C Lee Drug design, development and therapy, 1223-1233, 2013 | 55 | 2013 |
| Controversial effects of vitamin D and related genes on viral infections, pathogenesis, and treatment outcomes C Lee Nutrients 12 (4), 962, 2020 | 54 | 2020 |
| A small molecule inhibits HCV replication and alters NS4B's subcellular distribution PD Bryson, NJ Cho, S Einav, C Lee, V Tai, J Bechtel, M Sivaraja, ... Antiviral research 87 (1), 1-8, 2010 | 54 | 2010 |
| Binding dynamics of hepatitis C virus' NS5A amphipathic peptide to cell and model membranes NJ Cho, KH Cheong, CH Lee, CW Frank, JS Glenn Journal of virology 81 (12), 6682-6689, 2007 | 51 | 2007 |
| Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors G Jin, S Lee, M Choi, S Son, GW Kim, JW Oh, C Lee, K Lee European journal of medicinal chemistry 75, 413-425, 2014 | 47 | 2014 |
| Mangosteen xanthones suppress hepatitis C virus genome replication M Choi, YM Kim, S Lee, YW Chin, C Lee Virus genes 49, 208-222, 2014 | 43 | 2014 |
| Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase S Lee, KD Yoon, M Lee, Y Cho, G Choi, H Jang, BS Kim, DH Jung, JG Oh, ... British journal of pharmacology 173 (1), 191-211, 2016 | 42 | 2016 |
| Phosphatidylinositol 4, 5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome NJ Cho, C Lee, PS Pang, EA Pham, B Fram, K Nguyen, A Xiong, ... Gastroenterology 148 (3), 616-625, 2015 | 41 | 2015 |
| Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy C Lee Archives of pharmacal research 34 (9), 1403-1407, 2011 | 37 | 2011 |
| Carrageenans as broad-spectrum microbicides: current status and challenges C Lee Marine drugs 18 (9), 435, 2020 | 31 | 2020 |
| Inhibition of hepatitis C virus in mice by a small interfering RNA targeting a highly conserved sequence in viral IRES pseudoknot JS Moon, SH Lee, EJ Kim, H Cho, W Lee, GW Kim, HJ Park, SW Cho, ... PloS one 11 (1), e0146710, 2016 | 31 | 2016 |
